Literature DB >> 29280025

Management of nonfunctioning pituitary adenomas (NFAs): observation.

Wenyu Huang1, Mark E Molitch2.   

Abstract

Clinically nonfunctioning pituitary adenomas (NFAs) range from those causing significant hypothalamic/pituitary dysfunction and visual field compromise due to their large size to those being completely asymptomatic. In the absence of hypersecretion, hypopituitarism or visual field defects, patients with NFAs may be followed by periodic surveillance using MRI to detect tumor enlargement. In some cases, endocrine tests are also needed during observation to discover new pituitary dysfunction. Enlargement of NFAs without treatment occurs in about 10% of microadenomas and 23% of macroadenomas. Growth of a pituitary incidentaloma, the development of visual field defects or the development of hypopituitarism are potential indications for surgery during follow up.

Entities:  

Keywords:  Adenoma; Incidentaloma; Nonfunctioning; Observation; Pituitary; Tumor

Mesh:

Year:  2018        PMID: 29280025     DOI: 10.1007/s11102-017-0856-0

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  43 in total

Review 1.  Management of clinically non-functioning pituitary adenoma.

Authors:  Philippe Chanson; Gerald Raverot; Frédéric Castinetti; Christine Cortet-Rudelli; Françoise Galland; Sylvie Salenave
Journal:  Ann Endocrinol (Paris)       Date:  2015-06-10       Impact factor: 2.478

2.  Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.

Authors:  B M Arafah
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

Review 3.  Management of nonfunctioning pituitary incidentaloma.

Authors:  Françoise Galland; Marie-Christine Vantyghem; Laure Cazabat; Anne Boulin; François Cotton; Jean-François Bonneville; Emmanuel Jouanneau; Gwénaelle Vidal-Trécan; Philippe Chanson
Journal:  Ann Endocrinol (Paris)       Date:  2015-06-06       Impact factor: 2.478

4.  Prevalence of pituitary incidentaloma in the Iranian cadavers.

Authors:  K Aghakhani; M Kadivar; S Kazemi-Esfeh; N Zamani; M Moradi; H Sanaei-Zadeh
Journal:  Indian J Pathol Microbiol       Date:  2011 Oct-Dec       Impact factor: 0.740

5.  Pituitary incidentalomas: analysis of a neuroradiological cohort.

Authors:  César Esteves; Celestino Neves; Luís Augusto; Joana Menezes; Josué Pereira; Irene Bernardes; José Fonseca; Davide Carvalho
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 6.  Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis.

Authors:  M Mercè Fernández-Balsells; Mohammad Hassan Murad; Amelia Barwise; Juan F Gallegos-Orozco; Anu Paul; Melanie A Lane; Julianna F Lampropulos; Inés Natividad; Lilisbeth Perestelo-Pérez; Paula G Ponce de León-Lovatón; Patricia J Erwin; Jantey Carey; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

Review 7.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.

Authors:  Wolfgang Saeger; Dieter K Lüdecke; Michael Buchfelder; Rudolf Fahlbusch; Hans-Jürgen Quabbe; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2007-02       Impact factor: 6.664

8.  Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic.

Authors:  Mahmoud Messerer; Julie Dubourg; Gérald Raverot; David Bervini; Moncef Berhouma; Ipe George; Ari George Chacko; Gilles Perrin; Marc Levivier; Roy Thomas Daniel; Jacqueline Trouillas; Emmanuel Jouanneau
Journal:  Clin Neurol Neurosurg       Date:  2013-10-22       Impact factor: 1.876

9.  Pituitary gland: MR imaging of physiologic hypertrophy in adolescence.

Authors:  A D Elster; M Y Chen; D W Williams; L L Key
Journal:  Radiology       Date:  1990-03       Impact factor: 11.105

10.  Pituitary incidentaloma: an endocrine society clinical practice guideline.

Authors:  Pamela U Freda; Albert M Beckers; Laurence Katznelson; Mark E Molitch; Victor M Montori; Kalmon D Post; Mary Lee Vance
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

View more
  6 in total

1.  Impact of age on postsurgical outcomes of nonfunctioning pituitary adenomas.

Authors:  E Biamonte; N Betella; D Milani; G B Lasio; S Ariano; S Radice; E Lavezzi; G Mazziotti; A Lania
Journal:  Endocrine       Date:  2020-11-26       Impact factor: 3.633

2.  Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.

Authors:  Min Ho Lee; Kyu Yeon Hur; Sang Duk Hong; Ho Jun Seol; Jung Won Choi; Jung- Il Lee; Do-Hyun Nam; Doo-Sik Kong
Journal:  J Neurooncol       Date:  2021-05-17       Impact factor: 4.130

3.  Presentation, Management, and Outcomes of Nonfunctioning Pituitary Adenomas: An Experience from a Developing Country.

Authors:  Bhagwan Das; Sumera Batool; Adeel Khoja; Najmul Islam
Journal:  Cureus       Date:  2019-09-25

Review 4.  The diagnosis and management of Cushing's syndrome in pregnancy.

Authors:  Ross Hamblin; Amy Coulden; Athanasios Fountas; Niki Karavitaki
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

Review 5.  The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-10-29       Impact factor: 2.379

6.  FGFR2 gene polymorphism rs2981582 is associated with non-functioning pituitary adenomas in Chinese Han population: a case-control study.

Authors:  Bin Zhu; Juan Wang; Lingling Qin; Lei Wang; Yanfei Zheng; Lei Zhang; Wei Wang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.